Presentation is loading. Please wait.

Presentation is loading. Please wait.

Genetic Variation in GSTP1, Lung Function, Risk of Lung Cancer, and Mortality  Marianne S. Nørskov, MSc, PhD, Morten Dahl, MD, DMSc, Anne Tybjærg-Hansen,

Published byOswalda Beyer Modified over 5 years ago

Similar presentations

Presentation on theme: "Genetic Variation in GSTP1, Lung Function, Risk of Lung Cancer, and Mortality  Marianne S. Nørskov, MSc, PhD, Morten Dahl, MD, DMSc, Anne Tybjærg-Hansen,"— Presentation transcript:

1 Genetic Variation in GSTP1, Lung Function, Risk of Lung Cancer, and Mortality 
Marianne S. Nørskov, MSc, PhD, Morten Dahl, MD, DMSc, Anne Tybjærg-Hansen, MD, DMSc  Journal of Thoracic Oncology  Volume 12, Issue 11, Pages (November 2017) DOI: /j.jtho Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

2 Figure 1 Lung function according to glutathione S-transferase pi 1 gene (GSTP1) variants in the general population, overall and by smoking status. Data are presented as mean plus or minus SE. p Values were determined by test for trends. Numbers total slightly less than the number of all participants genotyped, as not all participants had spirometry performed. Ile105Val, amino acid isoleucine 105 changed to a valine; Ala114Val, amino acid alanine 114 changed to a valine; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity. Journal of Thoracic Oncology  , DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

3 Figure 2 Cumulative incidences of lung cancer and tobacco-related cancer as a function of glutathione S-transferase pi 1 gene (GSTP1) variants, after adjustment for death as a competing event. p Values are for trend tests across subhazard ratios in Fine-Gray models. Ile, isoleucine; Ala, alanine. Journal of Thoracic Oncology  , DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

4 Figure 3 Risk for development of lung cancer and tobacco-related cancer according to glutathione S-transferase pi 1 gene (GSTP1) variants in the general population. Hazard ratios were determined by Cox regression analysis. Multivariate adjusted models included age, sex, pack-years of smoking, and body mass index. p Values were determined by test for trends. Ile105Val, amino acid isoleucine 105 changed to a valine; Ala114Val, amino acid alanine 114 changed to a valine; CI, confidence interval. Journal of Thoracic Oncology  , DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

5 Figure 4 Cumulative incidence of all-cause mortality as a function of glutathione S-transferase pi 1 gene (GSTP1) variants. p Values were determined by test for trends. Abbreviations: Ile, isoleucine; Val, valine; Ala, alanine. Journal of Thoracic Oncology  , DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

6 Figure 5 Risk for all-cause mortality according to glutathione S-transferase pi 1 gene (GSTP1) variants in the general population, overall and by smoking status. Hazard ratios were determined by Cox regression analysis. Multivariate adjusted models included age, sex, pack-years of smoking, and body mass index. p Values were determined by test for trends. Ile105Val, amino acid isoleucine 105 changed to a valine; Ala114Val, amino acid alanine 114 changed to a valine; CI, confidence interval. Journal of Thoracic Oncology  , DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Genetic Variation in GSTP1, Lung Function, Risk of Lung Cancer, and Mortality  Marianne S. Nørskov, MSc, PhD, Morten Dahl, MD, DMSc, Anne Tybjærg-Hansen,"

Similar presentations

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages 1862-1863.

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Genetic Inhibition of CETP, Ischemic Vascular Disease.

Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Genetic Inhibition of CETP, Ischemic Vascular Disease.
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,
A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.
Morten Hoyer, Ph. D. , Henrik Roed, D. M. Sc

Morten Hoyer, Ph. D. , Henrik Roed, D. M. Sc
Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants  Ugo Pastorino, MD, Roberto Boffi, MD, Alfonso Marchianò, MD,

Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants  Ugo Pastorino, MD, Roberto Boffi, MD, Alfonso Marchianò, MD,
Brandon Stone, MD, Victor S. Mangona, MD, Matthew D

Brandon Stone, MD, Victor S. Mangona, MD, Matthew D
Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab  Tomoko Funazo,

Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab  Tomoko Funazo,
Two Classic Lyrics Joined by a Contemporary Tune—Environmental Pro-Carcinogen Exposure and Genetic Susceptibility in Lung Cancer Risk  Ping Yang, MD,

Two Classic Lyrics Joined by a Contemporary Tune—Environmental Pro-Carcinogen Exposure and Genetic Susceptibility in Lung Cancer Risk  Ping Yang, MD,
Chee Khoon Lee, PhD, Johnathan Man, M. B. B. S

Chee Khoon Lee, PhD, Johnathan Man, M. B. B. S
Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart.

Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart.
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,
Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind,

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind,
A Randomized, Placebo-Controlled, Multicenter, Biomarker-Selected, Phase 2 Study of Apricoxib in Combination with Erlotinib in Patients with Advanced.

A Randomized, Placebo-Controlled, Multicenter, Biomarker-Selected, Phase 2 Study of Apricoxib in Combination with Erlotinib in Patients with Advanced.
Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation  Don Hayes, MD, MS, Stephen Kirkby,

Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation  Don Hayes, MD, MS, Stephen Kirkby,
Brandon Stone, MD, Victor S. Mangona, MD, Matthew D

Brandon Stone, MD, Victor S. Mangona, MD, Matthew D
Incidence and Survival of Malignant Pleural Mesothelioma in Norway: A Population- Based Study of 1686 Cases  Åslaug Helland, MD, PhD, Steinar Solberg,

Incidence and Survival of Malignant Pleural Mesothelioma in Norway: A Population- Based Study of 1686 Cases  Åslaug Helland, MD, PhD, Steinar Solberg,
Effect of changes in postoperative spirometry on survival after lung transplantation  David P. Mason, MD, Jeevanantham Rajeswaran, MSc, Liang Li, PhD,

Effect of changes in postoperative spirometry on survival after lung transplantation  David P. Mason, MD, Jeevanantham Rajeswaran, MSc, Liang Li, PhD,
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
The Use of Systemic Treatment in the Maintenance of Patients with Non–Small Cell Lung Cancer: A Systematic Review  Swati Kulkarni, MD, Emily T. Vella,

The Use of Systemic Treatment in the Maintenance of Patients with Non–Small Cell Lung Cancer: A Systematic Review  Swati Kulkarni, MD, Emily T. Vella,

Similar presentations

Ads by Google